Ada Health Closes $90M Series B Led By Leaps By Bayer

The digital well being house continues cooking on fuel: Berlin-based Ada Health has closed a $90M Sequence B spherical of funding led by Leaps by Bayer, the affect funding arm of the German multinational pharma big, Bayer AG. Different traders within the spherical embody Samsung Catalyst Fund, Vitruvian Companions, Inteligo Financial institution, F4 and Mutschler Ventures.

The startup final raised round 4 years’ in the past, reporting a $47M Series A round in 2017. However don’t be fooled by the low lettering of those rounds: Ada Well being has been engaged on its symptom evaluation tech for round a decade at this level — relying, within the first a number of years of its mission, on personal funding from excessive internet price people in Germany and elsewhere in Europe. Initially it was additionally centered on constructing a call help software for medical doctors earlier than pivoting to straight addressing sufferers by way of an AI-driven symptom evaluation app. It’s not alone in providing this sort of software. Others within the house embody Babylon, Buoy, Okay Well being, Mediktor, Symptomate, WebMD and Your.MD — however Ada claims its app is probably the most used and highest rated by customers. It will probably additionally level to a peer reviewed study it led, which was revealed within the BMJ, and in contrast the situation protection, accuracy and security of eight rivals. The research discovered its app led the pack on all fronts.

One motive for that edge is that Ada Well being’s medical information base covers round 30,000 ICD-10 codes (aka the alphanumeric codes utilized by medical doctors to characterize completely different diagnoses) at this level — which co-founder and CEO,

 » Read more from